BLOOD SCIENCES
CRP, ESR and PV inflammation markers – a comparative review
David Norcliffe, David Manuel and Bernie Benson present a comparative review of the three commonly used methods to screen for inflammation markers to diagnose and monitor disease.
Inflammatory markers are blood tests used by healthcare professionals to detect inflammation, which aid in the diagnosis and monitor the progression of many diseases.1
After the total and
differential white cell count, which are part of the full blood count (FBC), the three most commonly used general inflammation markers to screen the wide range of organic diseases are, C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR) and plasma viscosity (PV). Numerous studies have highlighted advantages of each and conversely have also demonstrated limitations. The decision to commit to a particular test can therefore be an important one for clinicians and laboratory scientists, with many factors to consider, including the patient population being served. Hence,
an overall review may assist in the final decision-making process. In addition to their role as inflammatory markers, CRP and PV have also both been used as predictors of cardiovascular disease risks. PV on the other hand, has been shown to be influential in the aid of diagnosis and monitoring progression of other disorders like diabetes, cardiovascular diseases, dementia, Alzheimer’s disease and COVID-19.
C-reactive protein Discovered in 1930, the term CRP was derived from its initial identification as a substance present in the serum of patients experiencing acute inflammation, which exhibited a reaction with the ‘C’ carbohydrate antigen found in the capsule of pneumococcus.2
CRP
is a calcium-dependent acute phase protein of hepatic origin which binds to phosphocholine on the surface of dead or dying cells and some bacteria. It is now known to exist in at least three different forms: a monomeric (modified) form, a pentameric (natural or native) form and multimeric forms consisting of ten or more subunits.3
Other separate
forms have been described such as dimers, trimers, tetramers and non- native pentameric forms.4
Clinicians are
advised to exercise caution when making critical decisions based on the limited information provided by the CRP. CRP has a half-life of approximately 19 resulting in a continual variance in
hours5
Blood sciences departments commonly screen for C-reactive protein, erythrocyte sedimentation rate and plasma viscosity.
14
the plasma. Therefore, it’s understood to be very reactive and sensitive to changes, such as those seen in inflammation. The concentration of the reactive protein can change by approximately 5 mg/L in six hours and peak at 48 hours. Once inflammation subsides CRP levels reduce quickly.6
Hence it is used by many laboratories as a general infection marker MAY 2025
WWW.PATHOLOGYINPRACTICE.COM
AdobeStock / flashmovie
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
